Go Deep
Quest Laboratories Limited
Quest Laboratories Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,194 | 15.2 | 2.33 | 0.08 | 137.50 |
| Oct 2026 | 24,292 | 15.2 | 1.74 | 0.08 | 102.90 |
Quest Laboratories Limited Quarterly Results
| Line Item | Mar 2026 | Sep 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 324,046,000.0 | 256,200,000.0 | 464,519,000.0 |
| Net Profit | 28,705,000.0 | 40,164,000.0 | 19,370,000.0 |
| EPS | 1.7 | 2.5 | 1.2 |
Quest Laboratories Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 1,118,083,000.0 | 1,039,148,000.0 | 825,628,000.0 | 616,406,131.0 | — |
| Net Profit | 148,714,000.0 | 137,124,000.0 | 100,939,000.0 | 50,449,027.0 | — |
| EPS | — | 8.4 | 6.2 | 46.8 | 2.5 |
Quest Laboratories Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,121,871,000.0 | 1,217,958,000.0 | 605,375,000.0 | 482,467,000.0 | — |
| Total Liabilities | 153,652,000.0 | 398,453,000.0 | 318,694,000.0 | 331,416,000.0 | — |
| Total Equity | 968,219,000.0 | 819,505,000.0 | 286,681,000.0 | 151,051,000.0 | — |
Owes vs Owns
Quest Laboratories Limited owed ₹0.14 for every ₹1 it owned in Mar 2026, down from ₹0.69 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.14× | 0.33× | 0.53× | 0.69× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Quest Laboratories Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 11.0%Receivables 32.3%Inventory 34.4%Fixed assets (tangible) 14.5%Long-term investments 3.0%Other assets 4.9%
How it's funded — Mar 2026
Short-term debt 6.2%Long-term debt 0.8%Payables 5.0%Other liabilities 1.7%Shareholders' equity 86.3%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 12.3 | 49.3 | 6.9 | 2.7 |
| Receivables | 36.2 | 30.0 | 24.4 | 21.2 |
| Inventory | 38.6 | 21.4 | 16.1 | 11.2 |
| Fixed assets (tangible) | 16.3 | 11.9 | 10.2 | 9.9 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 3.3 | 2.9 | 0.0 | 0.0 |
| Other assets | 5.5 | 6.3 | 2.8 | 3.4 |
| Liabilities & equity | ||||
| Short-term debt | 7.0 | 28.9 | 4.2 | 2.9 |
| Long-term debt | 0.9 | 1.4 | 0.9 | 1.2 |
| Payables | 5.6 | 5.7 | 20.6 | 24.9 |
| Other liabilities | 1.9 | 3.9 | 6.2 | 4.1 |
| Shareholders' equity | 96.8 | 82.0 | 28.7 | 15.1 |
| Net tangible assets | 96.8 | 82.0 | 28.7 | 15.1 |
Quest Laboratories Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -106,417,000.0 | -232,928,000.0 | 30,133,000.0 | 38,794,338.0 | — |
| Investing Activities | 348,597,000.0 | -404,979,000.0 | -50,294,000.0 | -38,239,740.0 | — |
| Financing Activities | -242,262,000.0 | 674,285,000.0 | 20,394,000.0 | 30,187.0 | — |